Presentations

Lead AuthorAbstract TypeTitleDateEvent Name
Andrew SaykinVirtual PresentationLinking Central and Peripheral ADRD Related Changes: A Decade of Synergy Between the AD Metabolomics and Other Consortia including ADNI and CLEAR-AD12/11/2025Alzheimer’s Gut Microbiome Project (AGMP) Annual Meeting & External Advisory Board Meeting
Lindsey KuchenbeckerPresentationUntargeted proteomics and machine learning reveal novel biomarker candidates capturing diverse perturbed pathways in Alzheimer’s disease in an African American cohort12/2/2025Clinical Trials on Alzheimer’s Disease
Charisse WinstonPosterPre-analytical Characterization of CNS-Derived Extracellular Vesicles from Human Saliva: Effect of Room Temperature and Cellular Origin11/18/2025Society for Neuroscience
Shiwei LiuPosterEpigenetic signatures as indicators of Alzheimer’s Disease (AD)11/16/2025Society for Neuroscience – Neuroscience 2025
Ozkan IsPresentationProfiling microglia from Alzheimer’s disease rare risk variant carriers reveal protective and risk signatures11/15/2025Society For Neuroscience
Andrew SaykinPresentationThe Road to Personalized Medicine for Alzheimer’s Disease and Related Dementias11/1/2025University of Kentucky ADRC Fifteenth Annual Markesbery Symposium on Aging & Dementia
Andrew SaykinPresentationPrecision Health Strategies for Alzheimer’s Disease and Related Dementias: From Systems Biology to Biomarkers and Therapeutic Targets10/31/2025University of Kentucky ADRC Fifteenth Annual Markesbery Symposium on Aging & Dementia
Charisse WinstonPresentationCharacterization of Multiple CNS-Derived Salivary EV Populations for Alzheimer’s Biomarker Discovery10/30/20252nd Annual Extracellular Vesicles in Nervous System (EViNS) Symposium
Adelyn TsaiPosterCell type-specific gene expression changes are associated with cerebral amyloid angiopathy and blood-brain barrier integrity in Alzheimer’s disease7/30/2025Alzheimer’s Association International Conference
Mariet AllenPresentationMulti-omics studies reveal convergent and divergent pathways in Alzheimer’s and related disorders7/29/2025Alzheimer’s Association International Conference
Vanessa Colón BadilloPosterTargeted plasma eQTL and pQTL analyses to identify potential novel biomarkers for Alzheimer’s Disease in African Americans7/28/2025Alzheimer’s Association International Conference
Evgeny ChuminPosterPreliminary Characterization of Participant-Level Tau Brain Networks in the Health and Aging Brain Study – Health Disparities HABS-HD Cohort.07/27/25Alzheimer’s Association International Conference and the Alzheimer’s Imaging Consortium
Evgeny ChuminPosterFunctional connectivity network identifiability across a multi-year follow-up in the Korean Brain Aging Study for the Early Diagnosis and Prediction of AD07/27/25Alzheimer’s Association International Conference and the Alzheimer’s Imaging Consortium
Ozkan IsPosterSingle cell study of human brains and microglia discovers microglial protective and risk signatures driven by Alzheimer’s disease genetic factors.7/27/2025Alzheimer’s Association International Conference
Lindsey KuchenbeckerPresentationData-driven plasma biomarker discovery enables accurate classification of Alzheimer’s dementia in an African American cohort7/27/2025AAIC
Yuhao MinPosterFrom novel targets to potential therapies: development of antisense oligonucleotides for progressive supranuclear palsy7/27/2025Alzheimer’s Association International Conference
Xuan ChenPosterBlood-based genes and co-expression network levels are associated with AD/MCI diagnosis, cognitive, and neuroimaging phenotypes and preserved in the brain07/26/25Alzheimer’s Association International Conference
Merve AtikPosterIdentification of Novel Genetic Risk Factors for Cerebral Amyloid Angiopathy07/26/25Alzheimer’s Association International Conference
Andrew SaykinPresentationEndophenotypes, pathways, and the systems biology of AD/ADRD06/22/25Gordon Research Conference on Alzheimer’s Disease 2025: Multimodal Approaches to Mechanisms and Therapeutic Targets
Evgeny ChuminPosterCharacterization of individual tau-PET networks in Alzheimer’s disease and related dementia06/14/25Organization for Human Brain Mapping
Andrew SaykinPresentationTransformative Developments in Alzheimer’s Disease Research and Treatment06/11/25Mini-University, Indiana University Alumni Association
Andrew SaykinPresentationSystems Biology, Biomarkers, and Evolving Precision Health Strategies for Alzheimer’s Disease05/30/25Michigan ADRC Annual Symposium
Ozkan IsPresentationProfiling Microglia with Rare AD Variant Carriers04/04/25AD/PD 2025
Andrew SaykinVirtual PresentationPET as an Endophenotype for Genetic Studies of AD/ADRD03/12/25Novel Opportunities for PET Imaging Tracers in AD/ADRD and Emerging Tracers Workshop
Andrew SaykinVirtual PresentationGlobal proteomics approaches for deep characterization of CSF and matched plasma of cross-sectional and longitudinal samples from ADNI02/20/25ADNI Biofluid Biomarker Working Group
Olatunbosun ArowoloPosterA pilot study on the association of plasma proteins with neuroimaging biomarkers of Alzheimer’s disease in African Americans01/14/25Human Amyloid Imaging Conference
Cheyenne HurstPosterIntegration of network analysis of the plasma proteome with Alzheimer’s disease neuroimaging outcomes in an African American cohort01/14/25Human Amyloid Imaging conference
Lindsey KuchenbeckerOtherIntegration of data-driven biomarker discovery with established Alzheimer’s disease biomarkers in an African American cohort01/13/25Human Amyloid Imaging
Andrew SaykinVirtual PresentationPrecision Health in Alzheimer’s Disease: Systems Biology, Biomarkers and Prospects for Targeted Therapeutics10/25/24Cleveland Clinic Genome Center
Andrew SaykinPresentationProgress in the Genetics of Alzheimer’s Disease09/23/242024 NIA AD Summit
Samanth StricklandPresentationPreserved transcriptional networks in immune signaling pathways associated with chronic disease identified in Alzheimer’s disease and Parkinson’s disease, cross-tissue analysis08/01/24Alzheimer’s Association International Conference
Adelyn TsaiPosterDiscovery of Genes Underlying Cognitive Resilience in Individuals Predisposed to Alzheimer’s Disease Risk07/31/24Alzheimer’s Association International Conference
Xuan ChenPosterBlood-based gene and co-expression network levels are associated with AD/MCI diagnosis and cognitive phenotypes07/31/24Alzheimer’s Association International Conference
Lindsey KuchenbeckerPosterUntargeted plasma proteomics nominates a novel set of plasma biomarkers for Alzheimer’s disease in African Americans07/30/24Alzheimer’s Association International Conference
Joseph ReddyPosterMulti-omics profiling of Alzheimer’s disease in multi-ethnic populations07/29/24Alzheimer’s Association International Conference
Shiwei LiuPresentationIntegration of GWAS summary statistics with cell type-specific eQTLs prioritizes potential causal genes for Alzheimer’s disease07/28/24Alzheimer’s Association International Conference
Andrew SaykinPresentationEnabling Precision Medicine for AD/ADRD: From Cohort Studies to Clinical Trials07/26/24Alzheimer’s Association International Conference
Thea RosewoodPosterPathway Enrichment of Longitudinal AD Endophenotypes Identifies Potential Therapeutic Targets for Modifying Disease TrajectoryAlzheimer’s Association International Conference
Andrew SaykinPresentationThe CLEAR-AD Program07/25/247th Annual NIA-AA Symposium – Enabling Precision Medicine for Alzheimer’s Disease Through Open Science
Andrew SaykinPresentationNew frontiers in Alzheimer’s research and therapy: Harnessing data science and systems biology on the way to precision medicine06/06/243rd Annual Big Ten Neuroscience Meeting
Andrew SaykinPresentationDecoding Alzheimer’s Disease: A Journey from Imaging Genetics to Systems Biology en Route to Precision Medicine05/29/24Statistical Methods in Imaging Conference 2024